Nu Skin Enterprises Stock (NYSE:NUS)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$5.44

52W Range

$5.19 - $14.62

50D Avg

$6.76

200D Avg

$9.31

Market Cap

$263.63M

Avg Vol (3M)

$559.88K

Beta

0.95

Div Yield

$0.24 (4.42%)

NUS Company Profile


Nu Skin Enterprises, Inc. (NUS) is a global enterprise dedicated to the creation and worldwide distribution of beauty and wellness solutions. The company's diverse product offerings encompass advanced skincare systems, such as the ageLOC Spa and ageLOC Transformation age-defying lines, innovative devices like the ageLOC LumiSpa for comprehensive skin treatment and cleansing, and the ageLOC Boost, alongside various other cosmetic and personal care items. In the realm of health and nutrition, Nu Skin provides a comprehensive array of dietary and weight management products. This includes ageLOC Youth, LifePak, and ageLOC Meta nutritional supplements, in addition to ageLOC TR90 programs designed for weight control and body contouring, Beauty Focus Collagen+ skin care supplements, and other related weight management aids. The organization also significantly invests in research and development, particularly for its skincare and nutritional supplement portfolios. Nu Skin operates a network of retail stores and customer service centers exclusively within Mainland China. Its extensive product lines are marketed under its proprietary brands, which include Nu Skin, Pharmanex, and ageLOC. These products reach consumers through multiple sales channels, including direct-to-consumer interactions, an extensive network of independent distributors, and its dedicated e-commerce platform. Nu Skin Enterprises, Inc. was established in 1984 and maintains its corporate headquarters in Provo, Utah.

Show More

Industry

Household & Personal Products

Sector

Consumer Defensive

Exchange

NYSE

ADR

-

Country

US

Employees

3,100

IPO Date

Nov 22, 1996

Website

NUS Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Manufacturing Segment$205.79M$201.43M$181.40M
Rhyz Other Segment$17.79M$85.19M$35.21M
Nu Skin$1.14M$1.45B$1.75B

Fiscal year ends in Dec 25 | Currency in USD

NUS Financial Summary


Dec 25Dec 24Dec 23
Revenue$1.49B$1.73B$1.97B
Operating Income$65.76M$-151.59M$48.27M
Net Income$160.20M$-146.59M$8.60M
EBITDA$65.76M$-78.83M$202.98M
Basic EPS$3.25$-2.95$0.17
Diluted EPS$3.18$-2.95$0.17

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 08, 26 | 12:00 AM
Q4 25Feb 12, 26 | 12:00 AM
Q3 25Nov 07, 25 | 5:00 PM

Peer Comparison


TickerCompany
ABVEAbove Food Ingredients Inc. Common Stock
VLGEAVillage Super Market, Inc.
HELEHelen of Troy Limited
LINCLincoln Educational Services Corporation
BYNDBeyond Meat, Inc.
OTLYOatly Group AB
APEIAmerican Public Education, Inc.
MGPIMGP Ingredients, Inc.
QSGQuantaSing Group Ltd
VSTAVasta Platform Limited